AR026708A1 - Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma - Google Patents

Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma

Info

Publication number
AR026708A1
AR026708A1 ARP000106395A ARP000106395A AR026708A1 AR 026708 A1 AR026708 A1 AR 026708A1 AR P000106395 A ARP000106395 A AR P000106395A AR P000106395 A ARP000106395 A AR P000106395A AR 026708 A1 AR026708 A1 AR 026708A1
Authority
AR
Argentina
Prior art keywords
indazol
glaucoma
treatment
hydroxy
derivatives
Prior art date
Application number
ARP000106395A
Other languages
English (en)
Spanish (es)
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of AR026708A1 publication Critical patent/AR026708A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP000106395A 2000-03-17 2000-12-01 Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma AR026708A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19028300P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
AR026708A1 true AR026708A1 (es) 2003-02-26

Family

ID=22700701

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106395A AR026708A1 (es) 2000-03-17 2000-12-01 Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma

Country Status (12)

Country Link
EP (1) EP1268439A1 (enExample)
JP (1) JP2003535821A (enExample)
KR (1) KR20030095183A (enExample)
CN (1) CN1450995A (enExample)
AR (1) AR026708A1 (enExample)
AU (2) AU2001219180B2 (enExample)
BR (1) BR0017163A (enExample)
CA (1) CA2401959A1 (enExample)
MX (1) MXPA02008825A (enExample)
PL (1) PL365422A1 (enExample)
WO (1) WO2001070701A1 (enExample)
ZA (1) ZA200206853B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
WO2002098350A2 (en) 2001-06-01 2002-12-12 Alcon, Inc. Pyranoindazoles and their use for the treatment of glaucoma
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
US7196082B2 (en) 2002-11-08 2007-03-27 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
CN100384827C (zh) * 2002-11-08 2008-04-30 默克公司 用于治疗高眼压症的眼用组合物
CA2505127A1 (en) * 2002-11-08 2004-05-27 James B. Doherty Ophthalmic compositions for treating ocular hypertension
EP1581209A4 (en) 2002-12-13 2009-03-11 Alcon Inc NEW BENZOPYRAN ANALOGUE AND ITS USE FOR THE TREATMENT OF GLAUKOM
JP2004262812A (ja) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd 眼圧低下剤
AU2004271978B2 (en) * 2003-09-04 2009-02-05 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
AR046890A1 (es) 2003-12-15 2005-12-28 Alcon Inc [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma.
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
AU2005308523B2 (en) 2004-11-29 2010-01-07 Warner-Lambert Company Llc Therapeutic pyrazolo[3,4-b] pyridines and indazoles
US7425572B2 (en) 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
KR100972921B1 (ko) * 2009-12-02 2010-07-28 제이케이이앤씨 주식회사 회전 격판식 선회류 세정 및 탈취장치
WO2025000053A1 (en) * 2023-06-28 2025-01-02 Psylo Pty Ltd Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
WO1999059499A2 (en) * 1998-05-19 1999-11-25 Alcon Laboratories, Inc. Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
GB9819020D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds III
AU755119B2 (en) * 1998-09-18 2002-12-05 Alcon Laboratories, Inc. Serotonergic 5HT2 agonists for treating glaucoma

Also Published As

Publication number Publication date
MXPA02008825A (es) 2004-10-15
PL365422A1 (en) 2005-01-10
EP1268439A1 (en) 2003-01-02
WO2001070701A1 (en) 2001-09-27
AU2001219180B2 (en) 2005-04-07
JP2003535821A (ja) 2003-12-02
AU1918001A (en) 2001-10-03
KR20030095183A (ko) 2003-12-18
BR0017163A (pt) 2003-01-14
ZA200206853B (en) 2004-11-02
CA2401959A1 (en) 2001-09-27
CN1450995A (zh) 2003-10-22

Similar Documents

Publication Publication Date Title
AR026708A1 (es) Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma
BRPI0418245A (pt) nitróxi-derivados de prostaglandina
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
CY1114048T1 (el) Συνδυασμος βριμονιδινης και τιμολολης για τοπικη οφθαλμικη χρηση
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
ES2191286T3 (es) Moleculas pequeñas, utiles en el tratamiento de enfermedades inflamatorias.
CY1112946T1 (el) 4-υδροξυβενζομορφανια
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
PL374523A1 (en) Calicheamicin derivative-carrier conjugates
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
DE60331638D1 (de) Keratin-netzwerke enthaltende wundverbände für gewebedefekte
ECSP044862A (es) Pirenzepine ophthalmic gel
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
AR026707A1 (es) Agonistas de 5ht2 para el control de pio y para el tratamiento de glaucoma
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
AR022321A1 (es) Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada

Legal Events

Date Code Title Description
FB Suspension of granting procedure